PHQ-9 vs BDI-II: Which Depression Assessment Should You Use?
Compare PHQ-9 and BDI-II depression assessments. Learn when to use each, psychometric properties, HEDIS alignment, and clinical decision-making guidance.
PHQ-9HEDISFree
Patient Health Questionnaire-9
BDI-II
Beck Depression Inventory-II
Psychometric Properties
| Metric | PHQ-9 | BDI-II |
|---|---|---|
| Internal Consistency (α) | 0.86-0.89 | 0.92-0.93 |
| Test-Retest Reliability | 0.84 | 0.93 |
| Sensitivity | 88% | 91% |
| Specificity | 88% | 89% |
| Correlation with Clinical Diagnosis | 0.77 | 0.79 |
When to Use Each Assessment
Routine depression screening in primary care
Brief, free, HEDIS-aligned, and validated in medical settings
Tracking treatment response in therapy
Both are sensitive to change; PHQ-9 is more practical for frequent administration
Research requiring gold-standard measurement
Established research tool with extensive normative data
Value-based care contracts
Required for HEDIS depression measures; enables quality reporting
Detailed cognitive symptom assessment
More comprehensive coverage of hopelessness, worthlessness, guilt
Budget-conscious practice
No licensing fees; unlimited free use
Key Differences at a Glance
- PHQ-9 is free and public domain; BDI-II requires licensing fees
- PHQ-9 directly maps to DSM-5 criteria; BDI-II is conceptually aligned
- PHQ-9 is HEDIS-aligned for quality reporting; BDI-II is not
- BDI-II has more items covering cognitive symptoms like guilt and worthlessness
- PHQ-9 takes 2-3 minutes; BDI-II takes 5-10 minutes
The Bottom Line
For most clinical settings, the PHQ-9 is the recommended choice due to its brevity, zero cost, HEDIS alignment, and comparable psychometric properties. The BDI-II remains valuable for research contexts and when detailed cognitive symptom assessment is needed.
When to Use Both
Consider using PHQ-9 for routine screening and monitoring, with BDI-II for baseline and termination assessments in research-oriented practices or when detailed cognitive symptom tracking is clinically indicated.
Choosing between them in practice
For routine depression care the PHQ-9 wins on practicality: nine items, free, scored 0-27, and the instrument HEDIS depression measures are built around. The BDI-II is longer (21 items, 0-63) and licensed per administration, but covers cognitive symptoms — guilt, worthlessness, self-criticism — in far more depth, which is why it stays the reference measure in research and in psychology practices doing detailed formulation.
Score crosswalk
| Severity | PHQ-9 (0-27) | BDI-II (0-63) | Typical clinical action |
|---|---|---|---|
| Minimal / none | 0-4 | 0-13 | No treatment indicated; re-screen at the next routine visit |
| Mild | 5-9 | 14-19 | Watchful waiting, behavioral activation, repeat in 2-4 weeks |
| Moderate | 10-14 | 20-28 | Treatment plan indicated: therapy, medication or both |
| Moderately severe | 15-19 | 29-40 | Active treatment plus closer follow-up; consider medication |
| Severe | 20-27 | 41-63 | Immediate active treatment; assess safety and level of care |
Crosswalks are approximate. Severity bands from different instruments are not interchangeable, so keep one instrument as the measure of record for a given patient.
Switching instruments mid-treatment
- Do not compare a BDI-II total to a PHQ-9 total as if they were the same scale. A drop from 32 to 18 on the BDI-II is not a drop from 32 to 18 on the PHQ-9.
- When you switch instruments mid-episode, administer both once at the same visit. That single overlapping point gives you a defensible anchor for the new baseline.
- Set the new baseline from the first administration of the new instrument, then describe change against that baseline in every later note.
- If the switch is for quality reporting, switch to the PHQ-9: HEDIS depression measures require a total score from an instrument on the approved list, and the BDI-II is not on it.
Evidence notes
- PHQ-9 validation: Kroenke, Spitzer & Williams (2001), J Gen Intern Med 16(9):606-613. Sensitivity 88%, specificity 88% at a cut-off of 10.
- BDI-II manual: Beck, Steer & Brown (1996). Internal consistency 0.92-0.93 across psychiatric and community samples.
- A 5-point PHQ-9 change is the most widely cited minimum clinically important difference; the BDI-II equivalent is usually reported as 17.5% of the baseline score.
Frequently asked questions
Is the BDI-II better than the PHQ-9?
It is more detailed, not more accurate. Both detect depression at similar rates (sensitivity in the high 80s to low 90s). The BDI-II adds depth on cognitive and self-evaluative symptoms; the PHQ-9 adds speed, no licence cost, direct DSM-5 criterion mapping and quality-measure eligibility.
Can I convert a BDI-II score to a PHQ-9 score?
No published conversion is accurate enough for clinical use. Use the severity-band crosswalk above to describe a patient qualitatively, and re-baseline with the new instrument for any statement about change.
Which one counts for HEDIS depression measures?
The PHQ-9. HEDIS depression screening, follow-up and remission measures require a total score from an approved instrument; the PHQ-9 and PHQ-9M are the ones most plans accept. The BDI-II does not satisfy them.
Do I have to pay to use either one?
The PHQ-9 is free to use, copy and administer. The BDI-II is copyrighted and sold per administration, typically $2-3, which is the main reason programs tracking hundreds of patients standardize on the PHQ-9.
Ready to Use PHQ-9 or BDI-II?
Download printable forms or start tracking patient outcomes with TouchpointHQ.
5 Free Patients Forever
No credit card required • Full feature access